Lunai Bioworks Strengthens European Strategy Through Restructuring
-
Australia approves chlamydia vaccine for koalas
-
Lyles leads US medal charge in Tokyo, Kipyegon eyes fourth title
-
Kidnapped academic Elizabeth Tsurkov released in Iraq
-
'It was bananas': Colin Farrell shoots new movie in Macau casinos
-
De Minaur says Australia ready to snap Davis Cup title drought
-
Pacific Islands leaders kick off summit clouded by China tensions
-
Obese surpass undernourished youths for first time, UN warns
-
US Supreme Court to hear Trump tariff case in November
-
NBA Bulls re-sign Australian guard Giddey
-
Former Meta researchers testify company buried child safety studies
-
Trump issues rare rebuke to Netanyahu over Qatar strikes
-
US stocks close at fresh records, digesting weak jobs data
-
Bolsonaro on brink of conviction in Brazil coup trial
-
England set the standard with Serbia rout: Tuchel
-
Trump ready to match EU tariffs on China, India to pressure Putin: US official
-
Hong Kong legislature to vote on same-sex partnerships bill
-
Unconvincing France come from behind to edge Iceland in World Cup qualifying
-
England thrash Serbia, Haaland stars in World Cup qualifying
-
Sparkling England crush Serbia to ignite Tuchel's reign
-
Portugal edge Hungary in World Cup qualifying thriller
-
Trump issues rare rebuke to Netanyahu over Qatar strike
-
Cape Verde close to World Cup debut after beating Cameroon
-
Ganguly's Pretoria team lands big-hitting Brevis for record price
-
Apple's move to eSIM-only strengthens global trend
-
Macron names close ally Lecornu new PM
-
Afghanistan thrash Hong Kong in Asia Cup opener
-
Deadly Israeli strikes targeting Hamas in Qatar earn Trump rebuke
-
Pacific Islands leaders hold summit clouded by China tensions
-
Tedesco replaces Mourinho as Fenerbahce coach
-
Macron names defence minister Lecornu new PM: presidency
-
US unveils new health plan avoiding curbs on junk food, pesticides
-
Rotting body found in US rapper's Tesla in Hollywood
-
First of five judges in Bolsonaro coup trial votes to convict
-
Barca's Camp Nou not ready to host Valencia game
-
Stocks climb eyeing US rate cut, political turbulence
-
Concert cancellations just made us bigger, say Kneecap
-
Tedesco replaces Mourinho as Fenderbahce coach
-
Brazil's Supreme Court begins voting in Bolsonaro coup trial
-
Vuelta hit by protests again, Bernal wins stage
-
McIlroy takes Federer advice to avoid golf boredom
-
Israel strikes Hamas officials in Qatar
-
French fear diplomatic stitch-up over Bayeux Tapestry loan
-
Nepal protesters set parliament ablaze as PM quits
-
Russian attack kills 24 in Ukraine during pension distribution
-
Stocks climb as US rate cut hopes counter political shakeups
-
Romo abandons Vuelta after protest crash incident
-
Bayrou resigns as French PM, Macron seeks successor
-
Ethiopia inaugurates Africa's biggest dam, drawing Egyptian protest
-
Brazil's Supreme Court begins voting in Bolsonaro verdict
-
Miners Anglo American, Teck to forge copper giant
NYSE - LSE
| RBGPF | 2.38% | 77.27 | $ | |
| CMSD | -0.08% | 24.37 | $ | |
| SCS | -2.01% | 16.88 | $ | |
| RYCEF | -0.89% | 14.65 | $ | |
| NGG | -0.09% | 70.36 | $ | |
| GSK | 1.79% | 40.78 | $ | |
| CMSC | -0.12% | 24.14 | $ | |
| VOD | 0.51% | 11.86 | $ | |
| RELX | -0.25% | 47.19 | $ | |
| BCC | -4.37% | 85.29 | $ | |
| RIO | -2.99% | 61.87 | $ | |
| BCE | -0.79% | 24.2 | $ | |
| JRI | 0.36% | 13.78 | $ | |
| AZN | -0.42% | 81.22 | $ | |
| BTI | 0.12% | 56.26 | $ | |
| BP | 0.53% | 34.09 | $ |
Lunai Bioworks Strengthens European Strategy Through Restructuring
Company remains committed to Europe with a streamlined, growth-focused approach.
LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 8, 2025 / Lunai Bioworks Inc. (Nasdaq:RENB), an AI-powered drug discovery and biodefense company, today reaffirmed its long-term commitment to European markets and partnerships while announcing the elimination of its legacy subsidiary, Gedi Cube B.V., which has entered bankruptcy proceedings in the Netherlands.
"This allows us to move forward in Europe with a leaner, more focused model," said David Weinstein, Chief Executive Officer of Lunai Bioworks. "We remain deeply committed to building strategic collaborations across the continent and see significant opportunity to expand our AI-powered biodefense and drug discovery initiatives with new partners."
The restructuring of the European presence follows a comprehensive review of Lunai Bioworks' European business structure. The company emphasized that the bankruptcy of the subsidiary is not expected to have a material adverse impact on its ability to operate or pursue growth across Europe.
Key points for investors and stakeholders:
Streamlined Structure: Closing Gedi Cube B.V. eliminates legacy liabilities and simplifies European operations.
Focus on Growth Markets: Lunai Bioworks continues to prioritize partnerships with European pharma, biotech, and government agencies.
No Material Operational Impact: The bankruptcy is not expected to affect Lunai Bioworks' ability to deliver on global programs or partnerships.
Long-Term Commitment: Europe remains a key region in Lunai Bioworks' strategic roadmap, both for biodefense initiatives and therapeutic discovery collaborations.
By restructuring its European presence, Lunai Bioworks is aligning resources with its core mission - advancing safe and responsible AI for drug discovery and biodefense- while positioning for long-term growth in the region.
About Lunai Bioworks
Lunai Bioworks is an AI-powered drug discovery and biodefense company pioneering safe and responsible generative biology. With proprietary neurotoxicity datasets, advanced machine learning, and a focus on dual-use risk management, Lunai is redefining how artificial intelligence can accelerate therapeutic innovation while safeguarding society from emerging threats.
Media Contact:
David Weinstein
Chief Executive Officer
[email protected]
www.renovarogroup.com
SOURCE: Lunai Bioworks Inc.
View the original press release on ACCESS Newswire
A.Rodriguezv--AMWN
